157 related articles for article (PubMed ID: 37802293)
21. Frequent GNAQ, GNA11, and EIF1AX Mutations in Iris Melanoma.
Scholz SL; Möller I; Reis H; Süßkind D; van de Nes JAP; Leonardelli S; Schilling B; Livingstone E; Schimming T; Paschen A; Sucker A; Murali R; Steuhl KP; Schadendorf D; Westekemper H; Griewank KG
Invest Ophthalmol Vis Sci; 2017 Jul; 58(9):3464-3470. PubMed ID: 28700778
[TBL] [Abstract][Full Text] [Related]
22. GNAQ R183Q somatic mutation contributes to aberrant arteriovenous specification in Sturge-Weber syndrome through Notch signaling.
Huang L; Sun H; Liu Y; Xu L; Hu M; Yang Y; Wang N; Wu Y; Guo W
FASEB J; 2023 Sep; 37(9):e23148. PubMed ID: 37606556
[TBL] [Abstract][Full Text] [Related]
23. Mosaic Activating Mutations in GNA11 and GNAQ Are Associated with Phakomatosis Pigmentovascularis and Extensive Dermal Melanocytosis.
Thomas AC; Zeng Z; Rivière JB; O'Shaughnessy R; Al-Olabi L; St-Onge J; Atherton DJ; Aubert H; Bagazgoitia L; Barbarot S; Bourrat E; Chiaverini C; Chong WK; Duffourd Y; Glover M; Groesser L; Hadj-Rabia S; Hamm H; Happle R; Mushtaq I; Lacour JP; Waelchli R; Wobser M; Vabres P; Patton EE; Kinsler VA
J Invest Dermatol; 2016 Apr; 136(4):770-778. PubMed ID: 26778290
[TBL] [Abstract][Full Text] [Related]
24. A novel somatic mutation in GNAQ in a capillary malformation provides insight into molecular pathogenesis.
Galeffi F; Snellings DA; Wetzel-Strong SE; Kastelic N; Bullock J; Gallione CJ; North PE; Marchuk DA
Angiogenesis; 2022 Nov; 25(4):493-502. PubMed ID: 35635655
[TBL] [Abstract][Full Text] [Related]
25. Endothelial
Huang L; Bichsel C; Norris AL; Thorpe J; Pevsner J; Alexandrescu S; Pinto A; Zurakowski D; Kleiman RJ; Sahin M; Greene AK; Bischoff J
Arterioscler Thromb Vasc Biol; 2022 Jan; 42(1):e27-e43. PubMed ID: 34670408
[TBL] [Abstract][Full Text] [Related]
26. Mutations affecting G-protein subunit α11 in hypercalcemia and hypocalcemia.
Nesbit MA; Hannan FM; Howles SA; Babinsky VN; Head RA; Cranston T; Rust N; Hobbs MR; Heath H; Thakker RV
N Engl J Med; 2013 Jun; 368(26):2476-2486. PubMed ID: 23802516
[TBL] [Abstract][Full Text] [Related]
27. Mutation scanning of BRAF, NRAS, KIT, and GNAQ/GNA11 in oral mucosal melanoma: a study of 57 cases.
Lyu J; Wu Y; Li C; Wang R; Song H; Ren G; Guo W
J Oral Pathol Med; 2016 Apr; 45(4):295-301. PubMed ID: 26399561
[TBL] [Abstract][Full Text] [Related]
28. Prognostic impact of chromosomal aberrations and GNAQ, GNA11 and BAP1 mutations in uveal melanoma.
Staby KM; Gravdal K; Mørk SJ; Heegaard S; Vintermyr OK; Krohn J
Acta Ophthalmol; 2018 Feb; 96(1):31-38. PubMed ID: 28444874
[TBL] [Abstract][Full Text] [Related]
29. Chloroquine Sensitizes
Truong A; Yoo JH; Scherzer MT; Sanchez JMS; Dale KJ; Kinsey CG; Richards JR; Shin D; Ghazi PC; Onken MD; Blumer KJ; Odelberg SJ; McMahon M
Clin Cancer Res; 2020 Dec; 26(23):6374-6386. PubMed ID: 32933997
[TBL] [Abstract][Full Text] [Related]
30. In uveal melanoma Gα-protein GNA11 mutations convey a shorter disease-specific survival and are more strongly associated with loss of BAP1 and chromosomal alterations than Gα-protein GNAQ mutations.
Piaggio F; Croce M; Reggiani F; Monti P; Bernardi C; Ambrosio M; Banelli B; Dogrusöz M; Jockers R; Bordo D; Puzone R; Viaggi S; Coviello D; Lanza FB; Bartolucci M; Petretto A; Mosci C; Gangemi R; van der Velden PA; Jager MJ; Pfeffer U; Amaro A
Eur J Cancer; 2022 Jul; 170():27-41. PubMed ID: 35580369
[TBL] [Abstract][Full Text] [Related]
31. INPP5A phosphatase is a synthetic lethal target in GNAQ and GNA11-mutant melanomas.
Elbatsh AMO; Amin-Mansour A; Haberkorn A; Textor C; Ebel N; Renard E; Koch LM; Groenveld FC; Piquet M; Naumann U; Ruddy DA; Romanet V; Martínez Gómez JM; Shirley MD; Wipfli P; Schnell C; Wartmann M; Rausch M; Jager MJ; Levesque MP; Maira SM; Manchado E
Nat Cancer; 2024 Mar; 5(3):481-499. PubMed ID: 38233483
[TBL] [Abstract][Full Text] [Related]
32. GNAQ and GNA11 mutant nonuveal melanoma: a subtype distinct from both cutaneous and uveal melanoma.
Livingstone E; Zaremba A; Horn S; Ugurel S; Casalini B; Schlaak M; Hassel JC; Herbst R; Utikal JS; Weide B; Gutzmer R; Meier F; Koelsche C; Hadaschik E; Sucker A; Reis H; Merkelbach-Bruse S; Siewert M; Sahm F; von Deimling A; Cosgarea I; Zimmer L; Schadendorf D; Schilling B; Griewank KG
Br J Dermatol; 2020 Nov; 183(5):928-939. PubMed ID: 32064597
[TBL] [Abstract][Full Text] [Related]
33. The phosphoinositide 3-kinase α selective inhibitor BYL719 enhances the effect of the protein kinase C inhibitor AEB071 in GNAQ/GNA11-mutant uveal melanoma cells.
Musi E; Ambrosini G; de Stanchina E; Schwartz GK
Mol Cancer Ther; 2014 May; 13(5):1044-53. PubMed ID: 24563540
[TBL] [Abstract][Full Text] [Related]
34. Patient survival in uveal melanoma is not affected by oncogenic mutations in GNAQ and GNA11.
Koopmans AE; Vaarwater J; Paridaens D; Naus NC; Kilic E; de Klein A;
Br J Cancer; 2013 Jul; 109(2):493-6. PubMed ID: 23778528
[TBL] [Abstract][Full Text] [Related]
35. Identification of HRAS mutations and absence of GNAQ or GNA11 mutations in deep penetrating nevi.
Bender RP; McGinniss MJ; Esmay P; Velazquez EF; Reimann JD
Mod Pathol; 2013 Oct; 26(10):1320-8. PubMed ID: 23599145
[TBL] [Abstract][Full Text] [Related]
36. Comparative analysis of the GNAQ, GNA11, SF3B1, and EIF1AX driver mutations in melanoma and across the cancer spectrum.
Johnson DB; Roszik J; Shoushtari AN; Eroglu Z; Balko JM; Higham C; Puzanov I; Patel SP; Sosman JA; Woodman SE
Pigment Cell Melanoma Res; 2016 Jul; 29(4):470-3. PubMed ID: 27089234
[TBL] [Abstract][Full Text] [Related]
37. High frequency of GNA14, GNAQ, and GNA11 mutations in cherry hemangioma: a histopathological and molecular study of 85 cases indicating GNA14 as the most commonly mutated gene in vascular neoplasms.
Liau JY; Lee JC; Tsai JH; Chen CC; Chung YC; Wang YH
Mod Pathol; 2019 Nov; 32(11):1657-1665. PubMed ID: 31189994
[TBL] [Abstract][Full Text] [Related]
38. GNAQ and GNA11 mutations and downstream YAP activation in choroidal nevi.
Vader MJC; Madigan MC; Versluis M; Suleiman HM; Gezgin G; Gruis NA; Out-Luiting JJ; Bergman W; Verdijk RM; Jager MJ; van der Velden PA
Br J Cancer; 2017 Sep; 117(6):884-887. PubMed ID: 28809862
[TBL] [Abstract][Full Text] [Related]
39. Driver mutations in
García-Mulero S; Fornelino R; Punta M; Lise S; Varela M; Del Carpio LP; Moreno R; Costa-García M; Rieder D; Trajanoski Z; Gros A; Alemany R; Piulats JM; Sanz-Pamplona R
Oncoimmunology; 2023; 12(1):2261278. PubMed ID: 38126027
[TBL] [Abstract][Full Text] [Related]
40. Uveal melanoma driver mutations in GNAQ/11 yield numerous changes in melanocyte biology.
Perez DE; Henle AM; Amsterdam A; Hagen HR; Lees JA
Pigment Cell Melanoma Res; 2018 Sep; 31(5):604-613. PubMed ID: 29570931
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
